The pharmaceutical industry is calling on the FDA to modernise how it tracks the long-term safety and efficacy of cell and ...
A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback